EU Panel Backs New Pre-Filled Pen for Injecting Tralokinumab

A pre-filled pen that will halve the number of tralokinumab injections for patients with atopic dermatitis receives a positive opinion from the European Medicine Agency's CHMP.

Related Keywords

Switzerland ,Japan ,Liechtenstein ,Norway ,United States ,Saudi Arabia ,Canada ,Iceland ,United Arab Emirates ,United Kingdom ,Great Britain ,Leo Pharma ,European Union ,European Medicines Agency ,European Commission ,Committee For Medicinal Products Human Use ,Medicinal Products ,Human Use ,Dermatitis ,Europe ,European ,Skin ,Injectable Medications ,Skin And Soft Tissue Infection ,United Kingdom Site Content ,Biologic Therapy ,Atopic Dermatitis , ,Interleukins ,